Get started
Venus Remedies LimitedVenus Remedies LimitedVenus Remedies Limited

Venus Remedies Limited

No trades
OverviewFinancialsNewsCommunityTechnicalsSeasonals
Full chart
Full chart

Key stats


Market capitalization
‪12.20 B‬ INR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
16.50
Basic EPS (TTM)
57.10 INR
Net income (FY)
‪453.15 M‬ INR
Revenue (FY)
‪6.48 B‬ INR
Shares float
‪6.87 M‬
Beta (1Y)
0.65

Employees


Employees (FY)
‪1.3 K‬
Change (1Y)
+111 +9.35%
Revenue / Employee (1Y)
‪4.99 M‬ INR
Net income / Employee (1Y)
‪349.11 K‬ INR

About Venus Remedies Limited


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Ashutosh Jain
Website
venusremedies.com
Headquarters
Panchkula
Founded
1989
IPO date
Feb 15, 1995
Identifiers
2
ISIN INE411B01019
CFI code
ESVUFN
Venus Remedies Ltd. engages in the manufacture and trade of pharmaceutical products. Its products include analgesic, analgesic and antipyretic, anti diabetic, antibiotic, cardiac, disinfectant and antiseptic, gastro therapy, hand sanitizer, hormone, iron supplement, neurology, oncology, pain management, respiratory, skin care, stress reliever, urology, vitamins/minerals/nutrients, and wound management. The company was founded by Pawan Chaudhary on September 15, 1989 and is headquartered in Panchkula, India.

Check out other big names from the same industry as VENUSREM.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


The current price of VENUSREM is 942.65 INR — it has decreased by −3.04% in the past 24 hours. Watch Venus Remedies Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange Venus Remedies Limited stocks are traded under the ticker VENUSREM.
VENUSREM stock has fallen by −7.76% compared to the previous week, the month change is a −13.06% fall, over the last year Venus Remedies Limited has showed a 188.67% increase.
VENUSREM reached its all-time high on Apr 16, 2026 with the price of 1,119.00 INR, and its all-time low was 3.85 INR and was reached on Mar 23, 2004. View more price dynamics on VENUSREM chart.
See other stocks reaching their highest and lowest prices.
VENUSREM stock is 9.14% volatile and has beta coefficient of 0.65. Track Venus Remedies Limited stock price on the chart and check out the list of the most volatile stocks — is Venus Remedies Limited there?
Today Venus Remedies Limited has the market capitalization of ‪12.20 B‬, it has decreased by −6.59% over the last week.
Yes, you can track Venus Remedies Limited financials in yearly and quarterly reports right on TradingView.
VENUSREM net income for the last quarter is ‪255.80 M‬ INR, while the quarter before that showed ‪201.30 M‬ INR of net income which accounts for 0.00% change. Track more Venus Remedies Limited financial stats to get the full picture.
No, VENUSREM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 18, 2026, the company has ‪1.3 K‬ employees. See our rating of the largest employees — is Venus Remedies Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Venus Remedies Limited EBITDA is ‪1.08 B‬ INR, and current EBITDA margin is 10.18%. See more stats in Venus Remedies Limited financial statements.
Like other stocks, VENUSREM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Venus Remedies Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Venus Remedies Limited technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Venus Remedies Limited stock shows the buy signal. See more of Venus Remedies Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.